✦ LIBER ✦

384 Thymopentin in severe atopic eczema: Clinical and immunological evaluation

✍ Scribed by HSIEH, K; LIAO, T

Book ID: 119060566
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 152 KB
Volume: 87
Category: Article
ISSN: 1097-6825
DOI: 10.1016/0091-6749(91)91667-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and immunologic variables in sk

Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions

✍ Langeveld-Wildschut, Elisabeth G.; Bruijnzeel, Piet L.B.; Mudde, Geert C.; Versl 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 130 KB

A double-blind, placebo-controlled clini

A double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitis

✍ Stiller, Matthew J.; Shupack, Jerome L.; Kenny, Clare; Jondreau, Lorrie; Cohen, 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 690 KB

A retrospective evaluation of azathiopri

A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression

✍ L-A. Murphy; D. Atherton 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Background: Atopic eczema is a chronic inflammatory skin disease, which in most children can be adequately controlled using topical therapy. however, in a small number of children it is necessary to use systemic treatments to gain an acceptable level of disease control. ## Objectives: To evalu

Validation of the Eczema Area and Severi

Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme

✍ N. Barbier; C. Paul; T. Luger; R. Allen; Y. De Prost; K. Papp; L.f. Eichenfield; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB